Market Overview - The US stock market experienced a decline, with the Chinese concept index dropping by 0.94%. The Hang Seng Index fell by 110.27 points, a decrease of 0.41%, closing at 26,724.50 points, while the Hang Seng Tech Index dropped by 120.19 points, down 2.20%, reaching a new low since mid-July 2025 [1] - Technology stocks, particularly those considered riskier, continued to decline, with Tencent falling nearly 4% after restrictions on its "Yuanbao Red Packet" link by WeChat. Other major players like Baidu, Meituan, and Xiaomi also saw declines of over 2%, while Bilibili dropped nearly 5% [1] - Chip stocks faced significant losses, with Shanghai Fudan down nearly 9%, Huahong Semiconductor down over 5%, and SMIC down nearly 3% [1] - The coal sector showed strength, with Feishang No Smoke Coal rising over 33%. Real estate stocks also performed well, with Sunac China up over 7% and China Resources Land up nearly 4% [1] Corporate Developments - In the technology sector, InnoCare successfully completed a significant design integration for AI hardware with Google, establishing a solid foundation in the AI hardware market [1] - Enoch Intelligent received a milestone payment of HKD 39 million from Menarini, marking a significant step in its pharmaceutical technology research [1] - Capital investment firm Shumeng Capital signed a contract worth USD 3 million with a Macau distributor, expanding its business footprint [1] Pharmaceutical Industry Highlights - Youzhiyou Biotech's M701 received FDA IND approval for a novel therapy targeting malignant pleural effusion, marking a new phase in international clinical development [2] - Xiansheng Pharmaceutical received a milestone payment of USD 40 million from AbbVie for the overseas licensing option agreement for SIM0500, highlighting its competitiveness in the international pharmaceutical market [2] - Kangfang Biotech granted exclusive commercialization rights for Yixinning® to Jichuan Pharmaceutical, resulting in significant licensing fees and milestone payments [2] - Federal Pharmaceuticals' UBT251 injection received implied clinical trial approval for a new indication, providing new treatment options for patients [2] Food Industry Performance - Nissin Foods reported strong performance in its China business segment, with revenue reaching JPY 54.948 billion, a year-on-year increase of 2.7%, and core operating profit of JPY 5.859 billion, up 9.3% [2] Capital Market Insights - Guotai Junan International noted a market shift from "liquidity-driven" to "profit-driven" dynamics, suggesting a focus on fundamental analysis rather than speculative trading [4] - CITIC Securities observed significant adjustments in Hong Kong stock earnings expectations, predicting a continuation of the spring market rally with large-cap stocks outperforming [4] - Huatai Securities indicated that the current market sentiment has shifted to optimism, suggesting a focus on companies with earnings certainty and potential for growth in technology and cyclical sectors [5] - Guoyuan International highlighted that Hong Kong stocks may continue to outperform US stocks due to favorable conditions for non-US assets and the potential recovery of domestic demand [5]

Core Viewpoint - The Hang Seng Index opened down 1.06%, with the Hang Seng Tech Index falling by 1.29%. Gold stocks experienced significant declines, with Lingbao Gold down over 13%, China Gold International down over 12%, and Shandong Gold down over 10% [1]. Group 1: Market Outlook - Guoyuan International believes that under the current environment, Hong Kong stocks may continue to outperform U.S. stocks, showing a trend of oscillating upward. This is primarily due to the impact of the fiscal cliff and geopolitical factors, which continue to undermine the credibility of the U.S. dollar, thereby benefiting non-U.S. assets. As Hong Kong stocks are mainly composed of Chinese assets, they are expected to gain [1]. - Additionally, the long-term valuation level of Hong Kong stocks remains low, providing better elasticity. Currently, the overall valuation of Hong Kong stocks has not fully reflected the recovery of the domestic economy. From the credit situation, the demand for credit from domestic enterprises may have already recovered. If this trend continues, the improvement in domestic demand is likely to become a new investment theme for Hong Kong stocks, boosting investor sentiment and attracting more incremental capital [1]. Group 2: Earnings Expectations - CITIC Securities indicates that the earnings expectations for Hong Kong stocks have undergone significant adjustments, and the disturbances from internal and external capital have also come to a pause. The institution predicts that the spring market since late December 2025 may continue, with large-cap stocks showing relative returns before the Spring Festival, while growth sectors supported by policy directions are expected to perform better [1]. - Attention should be paid to the next peak period of stock unlocks after spring, as it may impact liquidity expectations for Hong Kong stocks [1].

Market Performance - The Hang Seng Index closed at 27,387.11 points, down 580.98 points, a decline of 2.08%, despite a monthly increase of nearly 7% and reaching a nearly four-and-a-half-year high earlier in the week [1] - The Hang Seng Tech Index closed at 5,718.18 points, down 122.92 points, a decline of 2.10% [3] Sector Performance - Gold stocks experienced significant declines due to fluctuations in international precious metal prices, with Shandong Gold down over 14%, Jiangxi Copper down over 10%, and several others including Zijin Mining and Zhaojin Mining down over 9% [5] - Technology stocks broadly declined, with Kuaishou and Xiaomi down over 3%, Tencent and Alibaba down over 2%, and others like Baidu, Lenovo, Meituan, JD.com, and Bilibili down over 1% [6] - Oil stocks also saw a general decline, with PetroChina down over 1% [6] - Solar energy stocks weakened, with Flat Glass down over 6%, and innovative drug concepts mostly fell, with CSPC Pharmaceutical down over 10% [6] Market Sentiment and Regulatory Actions - Spot gold and silver prices dropped significantly, with gold falling below $5,120 per ounce and silver below $108 per ounce, leading to several gold-related companies issuing risk warnings about significant price deviations from market indices [7] - Regulatory measures, such as increased margin requirements by the Shanghai Futures Exchange, aim to cool the speculative atmosphere in the market [7] Future Outlook - CITIC Securities anticipates that the downward adjustments in earnings expectations and funding disturbances affecting the Hong Kong stock market will conclude, predicting a continuation of the spring market trend since late December 2025, with large-cap stocks expected to perform relatively well before the Lunar New Year [9] - Industrial growth sectors supported by policy direction are expected to outperform [9] - Industrial funds believe that technology assets in the Hong Kong market hold significant allocation value for both domestic and international investors due to their scarcity and relatively low valuations, with potential for diverse investment trends in 2026 [9]

Group 1 - The core viewpoint of the article suggests that the current Hong Kong stock market environment may resemble last year's "spring rally," driven by weak overseas liquidity expectations and advancements in AI applications [1] - The Hong Kong Stock Connect 50 ETF (159712) tracks the Hong Kong Stock Connect 50 Index (930931), which selects the 50 largest listed companies within the Stock Connect framework, covering both new and traditional economic sectors [1] - The index emphasizes sectors such as finance, consumption, and information technology to reflect the overall performance of core listed companies in the Hong Kong Stock Connect [1]